Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|August 4, 2025
The incidence and mortality of connective tissue diseases: a population-level cohort study in England from 2012 to 2023Samir Patel, Mark D Russell, Katie Bechman, et al.
The Journal of Infection|July 17, 2024
The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19Katie Bechman, Amelia Ca Green, Mark D Russell, et al.
Rheumatology (Oxford, England)|May 10, 2022
Worse outcomes linked to ethnicity for early inflammatory arthritis in England and Wales: a national cohort studyMaryam A Adas, Sam Norton, Sathiyaa Balachandran, et al.
Rheumatology (Oxford, England)|September 19, 2023
Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis AuditKatie Bechman, Emma S Cook, Edward Alveyn, et al.
Rheumatology (Oxford, England)|June 30, 2025
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors- a review of the literatureDeepak Nagra, Kaiyang Song, Joy Odia, et al.
Current Research in Translational Medicine|February 15, 2021
Biological responses to COVID-19: Insights from physiological and blood biomarker profilesRosita Zakeri, Andrew Pickles, Ewan Carr, et al.
Rheumatology (Oxford, England)|June 4, 2024
Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort studyDeepak Nagra, Katie Bechman, Mark D Russell, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
The Journal of Infection|March 22, 2021
IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regressionEmmanuel Tharmarajah, April Buazon, Vishit Patel, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Pageof 8